Vitamin supplement efficacy studies
Pro Research Analysisby 
Searched over 200M research papers
Vitamin Supplement Efficacy: Overview from Recent Studies
Research on vitamin supplements covers a wide range of health outcomes, including vitamin status, mental health, cardiovascular disease, inflammation, and specific chronic conditions. The efficacy of these supplements varies depending on the vitamin, the health outcome measured, and the population studied.
Vitamin D Supplementation: Efficacy in Different Health Outcomes
Improving Vitamin D Status and Related Biomarkers
Cholecalciferol (vitamin D3) is more effective than ergocalciferol (vitamin D2) in raising serum vitamin D levels and reducing parathyroid hormone (PTH) levels, regardless of participant demographics, dosage, or supplementation method. The difference in efficacy is most pronounced at higher doses, with average daily dose being the main predictor of effect size .
Inflammation and Oxidative Stress
Vitamin D supplementation significantly reduces markers of inflammation and oxidative stress, such as C-reactive protein (CRP), tumor necrosis factor-alpha (TNF-α), and malondialdehyde (MDA). However, it does not significantly affect interleukin-6 (IL-6), total antioxidant capacity, or glutathione activity. These findings suggest vitamin D can be considered as an adjunct therapy for reducing inflammation and oxidative stress in adults .
Acute Respiratory Infections
Overall, vitamin D supplementation does not significantly prevent acute respiratory infections (ARIs). Some benefit is seen with daily or short-term supplementation, but these effects are not confirmed in high-quality studies, and publication bias is present .
Depression and Mental Health
The evidence for vitamin D supplementation in improving depressive symptoms is mixed. Some studies show no significant benefit in older adults, with efficacy influenced by baseline vitamin D levels, dosage, gender, and initial depression status . However, when studies are carefully designed without biological flaws, vitamin D supplementation (≥800 IU daily) shows a significant improvement in depression, with effect sizes comparable to antidepressant medications . Vitamin D, along with B vitamins, may also serve as an effective and well-tolerated adjunct to standard treatments for depression and anxiety, though results for anxiety are more limited Borges-Vieira2022Schefft2017.
B Vitamins and Mental Health
Supplementation with B vitamins (such as folic acid, B1, B12, and L-methylfolate) can significantly decrease depression scores, either as an adjunct to standard pharmacological treatment or as monotherapy. The evidence for anxiety is less robust and mainly limited to studies of vitamin D as an adjunct . For vitamin B12, the available data is positive but limited, and for folic acid, meta-analyses do not support efficacy in depression .
Cardiovascular Disease Prevention
Large-scale meta-analyses show that vitamin and antioxidant supplements, in general, do not reduce the risk of major cardiovascular events. There is no consistent benefit across different types of vitamins, antioxidants, or cardiovascular outcomes. Some marginal benefits are seen with low-dose vitamin B6 and vitamin E in specific subgroups, but these effects are not robust in high-quality trials . Another network meta-analysis suggests that vitamins B, D, and E may reduce the incidence of cardiovascular events to varying degrees, with vitamin D ranking highest for prevention and vitamin E for reducing cardiovascular death, but combinations of vitamins do not show improved efficacy .
Inflammatory Rheumatic Disorders
Oral vitamin supplementation, including vitamin D, E, folic acid, and K, does not significantly reduce disease activity or symptoms in rheumatoid arthritis (RA). Folic acid is recommended to prevent methotrexate-related side effects, and vitamin D is advised for those with deficiency to prevent musculoskeletal complications, but evidence for efficacy in reducing RA activity is limited .
Conclusion
The efficacy of vitamin supplements is highly dependent on the specific vitamin, health outcome, and study quality. Vitamin D3 is superior to D2 for improving vitamin D status. Vitamin D may help reduce inflammation and oxidative stress, and can be beneficial for depression when studies are well-designed. B vitamins show promise for depression, but not all (e.g., folic acid) are effective. For cardiovascular disease and inflammatory rheumatic disorders, vitamin supplements generally do not provide significant preventive or therapeutic benefits. High-quality, targeted research is essential to clarify the role of vitamin supplements in specific populations and conditions.
Sources and full results
Most relevant research papers on this topic
Relative Efficacy of Vitamin D2 and Vitamin D3 in Improving Vitamin D Status: Systematic Review and Meta-Analysis
Cholecalciferol is more effective than ergocalciferol in improving vitamin D status and regulating PTH levels, regardless of participant demographics, dosage, and supplementation vehicle.
Efficacy of B-vitamins and vitamin D therapy in improving depressive and anxiety disorders: a systematic review of randomized controlled trials
B vitamins and vitamin D supplementation may effectively improve symptoms of depression and anxiety when used alongside standard treatments, depending on the patient's clinical status and nutritional biomarkers.
Efficacy of vitamin and antioxidant supplements in prevention of cardiovascular disease: systematic review and meta-analysis of randomised controlled trials
There is no evidence to support the use of vitamin and antioxidant supplements for prevention of cardiovascular diseases.
Efficacy of adding nutritional supplements in unipolar depression: A systematic review and meta-analysis.
Adding nutritional supplements to antidepressants may be effective for treating unipolar depression, but more data is needed for most substances.
DOI